Literature DB >> 8960739

Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy.

J Pujol1, J Kulisevsky, A Moreno, J Deus, J Alonso, J Balanzó, J L Martí-Vilalta, A Capdevila.   

Abstract

In patients with chronic hepatic encephalopathy, proton magnetic resonance spectroscopy can be used to detect specific metabolic abnormalities in the brain; MRI shows a hyperintense globus pallidus on T1-weighted sequences. We investigated the relationship between these two MR findings in a series of 25 patients with the use of quantitative data and a multiple regression analysis model. The cerebral increase in glutamine compounds and the decrease in myoinositol and choline correlated separately with globus pallidus hyperintensity, and each was complementary in accounting for this imaging finding. Such as association suggests that spectroscopic and imaging alterations are two different expressions of the reversible events that occur in the brain of patients with hepatic encephalopathy in that both disappear after liver transplantation. Globus pallidus hyperintensity seems to be a global indicator of the cerebral metabolic disorder, and the spectroscopic pattern denotes the specific metabolic alterations.

Entities:  

Mesh:

Year:  1996        PMID: 8960739     DOI: 10.1212/wnl.47.6.1526

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

Review 2.  The basal ganglia and portal-systemic encephalopathy.

Authors:  K Weissenborn; H Kolbe
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

3.  Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Authors:  Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2015-08-08       Impact factor: 3.584

Review 4.  Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.

Authors:  H Köstler
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 5.  Functional imaging of the brain in patients with liver cirrhosis.

Authors:  Karin Weissenborn; Martin Bokemeyer; Björn Ahl; Daniela Fischer-Wasels; Kathrin Giewekemeyer; Jörg van den Hoff; Herbert Köstler; Georg Berding
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

Review 7.  Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.

Authors:  V-P Bob Grover; M-Alex Dresner; Daniel-M Forton; Serena Counsell; David-J Larkman; Nayna Patel; Howard-C Thomas; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

8.  Acute hepatic encephalopathy presenting as cortical laminar necrosis: case report.

Authors:  Jong Mun Choi; Yoon Hee Kim; Sook Young Roh
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

9.  Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.

Authors:  Karin Weissenborn; Björn Ahl; Daniela Fischer-Wasels; Joerg van den Hoff; Hartmut Hecker; Wolfgang Burchert; Herbert Köstler
Journal:  Gut       Date:  2007-07-27       Impact factor: 23.059

10.  Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels.

Authors:  D M Forton; N Patel; M Prince; A Oatridge; G Hamilton; J Goldblatt; J M Allsop; J V Hajnal; H C Thomas; M Bassendine; D E J Jones; S D Taylor-Robinson
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.